Yemi Adesokan is chief scientific officer at Gnubiotics SA, a Lausanne, Switzerland-based biotech company developing milk oligosaccharide biosimilars for humans and companion animals. He has been recognized for his innovative and pioneering work with awards such as the 2012 Boston Business Journal 40 under 40 award and the 2011 MIT Technology Review’s annual list of 35 top global innovators under the age of 35. Adesokan has a doctorate in chemistry from the University of California, Irvine, and completed a post-doctoral fellowship in genetics at Harvard Medical School.